Summary
Latest filing:
Barry M. Salzman is Director of Checkpoint Therapeutics, Inc. (CKPT). 1 SEC Form 4 filing on record, dated 17 December 2024.
Recent Transactions
1Every recent SEC Form 4 transaction Barry M. Salzman has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Barry M. Salzman. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James F. Oliviero III - $3.07M of CKPT open-market activity on record
- William Garrett Gray - $1.08M of CKPT open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Barry M. Salzman?
Barry M. Salzman is a corporate insider, tracked as Director of Checkpoint Therapeutics, Inc. (CKPT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Barry M. Salzman last file a Form 4?
The only primary Form 4 on record is dated 17 December 2024.
Where can I see all of Barry M. Salzman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Barry M. Salzman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
